LIMNW

Conviction 0HealthcareScan · Thu, Jun 25, 2026

LIMNW$0.0000-100.00%

ResistanceSupportVol 14

Vol MA14 292.143

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

Liminatus Pharma, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)liminatuspharma.com ↗

Price0.0000

Change-100.00%

Gap-100.00%

Rel volume0.00×

Avg volume2.48K

Avg $ vol219.98

SMA 200.0289

SMA 500.0350

SMA 2000.0500

Price vs 50-100.00%

Price vs 200-100.00%

MA stackbearish

50/200 cross—

Supertrenddown · 0.0760

RSI (14)47

MACD hist-0.00

MACD crossbear · 0d

Stoch %K / %D0 / 21

ADX (14)8

+DI / −DI50 / 45

RSI divergence—

MACD divergence—

ATR %—

ADR %16.77%

52w high0.3900

52w low0.0000

From 52w high-100.00%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width554.08%

%B0.32

Donchian pos0.00%

Donchian high0.1075

Donchian low0.0000

AVWAP (52w high)0.1768

vs AVWAP high-100.00%

AVWAP (52w low)0.1102

vs AVWAP low-100.00%

OBV trendUp

Chaikin MF (20)-0.65

Today vs 20d0.00×

Avg vol (14d)292

Avg vol (20d)2.48K

Avg $ vol (20d)219.98

Market cap0

RS 3m (vs SPY)—

RS 6m (vs SPY)-107.74%

RS line new highNo

Trend template0/7

Technical rank—

1 week—

1 month-100.00%

3 months—

6 months-100.00%

1 year-100.00%

YTD-100.00%

P/E0.00

P/B0.00

P/S—

P/FCF0.00

EPS-0.4300

Div yield—

ROE—

ROA-365.79%

Debt/Eq-10.88

Current0.96

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-187.81%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.44M

Revenue—

Net income-1.12M

Gross profit—

Free cash flow-9.98M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out7.74M

Employees1

ListedThu, May 1, 2025

Free float—

Float %—

Short interest1.99K

Days to cover0.2d

Short volume—

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank—

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0996

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LIMNW

All disclosures →

No recent disclosed trades by Congress in LIMNW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LIMNW

No recent insider (Form 4) filings in LIMNW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LIMNW

EDGAR →

No recent SEC filings on file for LIMNW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.